ambrisentan

FDA Drug Profile — ambrisentan, Ambrisentan

ambrisentan is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including ambrisentan, Ambrisentan. Available dosage form: tablet, film coated.

Drug details

Generic Name
ambrisentan
Brand Names
ambrisentan, Ambrisentan
Application Number
ANDA210784
Sponsor
Sun Pharmaceutical Industries, Inc.
NDC Codes
8
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
AMBRISENTAN

Indications and Usage

1 INDICATIONS AND USAGE Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). Ambrisentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included trials predominantly in patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%) ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.